(Press-News.org) Researchers at Nationwide Children's Hospital report a gene therapy strategy that improves the condition of a mouse model of an inherited blood disorder, Beta Thalassemia. The gene correction involves using unfertilized eggs from afflicted mice to produce a batch of embryonic stem cell lines. Some of these stem cell lines do not inherit the disease gene and can thus be used for transplantation-based treatments of the same mice. Findings could hold promise for a new treatment strategy for autosomal dominant diseases like certain forms of Beta Thalassemia, tuberous sclerosis or Huntington's disease.
Embryonic stem cells have the potential to produce unlimited quantities of any cell type and are therefore being explored as a new therapeutic option for many diseases. Unfertilized eggs can be cultured to form embryonic stem cells, so-called parthenogenetic embryonic stem cells.
"Parthenogenetic embryonic stem cells can differentiate into multiple tissue types as do stem cells from fertilized embryos," said K. John McLaughlin, PhD, principal investigator in the Center for Molecular and Human Genetics at The Research Institute at Nationwide Children's Hospital. Previously, the group demonstrated that blood cells derived from parthenogenetic cells could provide healthy, long-term blood replacement in mice.
"Advantages of parthenogenetic stem cells are not only that fertilization is not needed, but also that the recipient's immune system may potentially not view them as foreign, minimizing rejection problems. Furthermore, since parthenogenetic embryonic stem cells are derived from reproductive cells which contain only a single set of the genetic information instead of the double set present in body cells, they may not contain certain abnormal genes present in the other copy," said Dr. McLaughlin also one of the study authors.
A single copy of an abnormal gene inherited from one parent can cause so-called autosomal dominant diseases such as tuberous sclerosis or Huntington's disease. The affected person has one defective and one normal copy of the gene, but the abnormal gene overrides the normal gene, causing disease. In normal sexual reproduction, each parent provides one gene copy to offspring via their reproductive cells. Therefore, the reproductive cells of a patient with an autosomal dominant disease could either pass along a defective copy or a normal copy.
"As the donor patient has one defective gene copy and one normal, and only one copy is used for normal reproduction, we can select egg-cell-derived embryonic stem cells with two normal copies," said Dr. McLaughlin. "These single-parent/patient-derived embryonic stem cells can theoretically be used for correction of a diverse number of diseases that occur when one copy of the gene is abnormal," said Dr. McLaughlin.
To test this theory, Dr. McLaughlin and colleagues from the University of Pennsylvania, University of North Carolina and University of Minnesota, examined whether parthenogenetic embryonic stem cells could be used for tissue repair in a mouse model of thalassemia intermedia. Thalassemia intermedia is an inherited blood disorder in which the body lacks sufficient normal hemoglobin, leading to excessive destruction of red blood cells and anemia. They used a mouse model in which one defective gene copy causes anemia.
Using approaches developed from a previous study done by this group, Nationwide Children's Research Fellow Sigrid Eckardt, PhD, derived embryonic stem cells from the unfertilized eggs of female mice with the disease, and identified those stem cell lines that contained only the "healthy" hemoglobin genes. These "genetically clean" embryonic stem cell lines were converted into cells that were transplanted into afflicted mice that were carriers of the disease causing gene. Blood samples drawn five weeks after transplantation revealed that the delivered cells were present in the recipients' blood. Their red blood cells were also corrected to a size similar to normal mice and red blood cell count, hematocrit and hemoglobin levels became normal.
"Overall, we observed long-term improvement of thalassemia in this model," said Dr. Eckardt. "Our findings suggest that using reproductive cells to generate embryonic stem cells that are 'disease-free' may be a solution for genetic diseases involving large, complex or poorly identified deletions in the genome or that are not treatable by current gene therapy approaches." Dr. McLaughlin says that this approach also contrasts with typical gene therapy approaches in that it requires no engineering of the genome, which is currently difficult to achieve in human embryonic and embryonic-like (IPS) stem cells.
INFORMATION: END
Using biological samples taken from patients and state-of-the-art biochemical techniques, a Florida State University researcher is working to identify a variety of "biomarkers" that might provide earlier warnings of the presence of breast and prostate cancers.
"Biomarkers are indicators of certain biological and pathological processes that are occurring, such as cancer," said Qing-Xiang "Amy" Sang, a professor in Florida State's Department of Chemistry and Biochemistry. "Either the cancer cells themselves, or surrounding normal tissue for that matter, can produce specific ...
UCLA researchers have found that a protein that plays an important role in some antioxidant therapies may not be as effective due to additional mechanisms that cause it to promote atherosclerosis, or clogging of the arteries.
Published in the January issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology, the finding may give clues as to why some antioxidant therapies have not yielded more positive results.
The protein, called Nrf2, has been thought to be an important drug-therapy target for diseases such as cancer because it can induce chemopreventive ...
Persistence paid off for a University of Alberta paleontology researcher, who after months of pondering the origins of a fossilized jaw bone, finally identified it as a new species of pterosaur, a flying reptile that lived 70 million years ago.
Victoria Arbour says she was stumped when the small piece of jaw bone was first pulled out of of a fossil storage cabinet in the U of A's paleontology department.
"It could have been from a dinosaur, a fish or a marine reptile," said Arbour. "
Arbour, a PhD student in paleontology, says the first clue to the fossil's identify ...
Glass stronger and tougher than steel? A new type of damage-tolerant metallic glass, demonstrating a strength and toughness beyond that of any known material, has been developed and tested by a collaboration of researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab)and the California Institute of Technology. What's more, even better versions of this new glass may be on the way.
"These results mark the first use of a new strategy for metallic glass fabrication and we believe we can use it to make glass that will be even ...
Washington, D.C. — Sophisticated tools allow scientists to subject the basic elements of matter to conditions drastic enough to modify their behavior. By doing this, they can expand our understanding of matter. A research team including three Carnegie scientists was able to demonstrate surprising properties of the element lithium under intense pressure and low temperatures. Their results were published Jan. 9 on the Nature Physics website.
Lithium is the first metal in the periodic table and is the least dense solid element at room temperature. It is most commonly known ...
DURHAM, N.H. – An international team of researchers, including several from the University of New Hampshire, have completed the first DNA sequence of any strawberry plant, giving breeders much-needed tools to create tastier, healthier strawberries. Tom Davis, professor of biological sciences at UNH, and postdoctoral researcher Bo Liu were significant contributors to the genome sequence of the woodland strawberry, which was published last month in the journal Nature Genetics.
"We now have a resource for everybody who's interested in strawberry genetics. We can answer questions ...
NJIT Distinguished Professor Philip R. Goode and the research team at Big Bear Solar Observatory (BBSO) have reported new insights into the small-scale dynamics of the Sun's photosphere. The observations were made during a period of historic inactivity on the Sun and reported in The Astrophysical Journal . http://iopscience.iop.org/2041-8205/714/1/L31 The high-resolution capabilities of BBSO's new 1.6-meter aperture solar telescope have made such work possible.
"The smallest scale photospheric magnetic field seems to come in isolated points in the dark intergranular ...
PROVIDENCE, R.I. [Brown University] — In the longest-term study so far to track people with body dysmorphic disorder, a severe mental illness in which sufferers obsess over nonexistent or slight defects in their physical appearance, researchers at Brown University and Rhode Island Hospital found high rates of recovery, although recovery can take more than five years.
The results, based on following 15 sufferers of the disease over an eight-year span, appear in the current issue of the Journal of Nervous and Mental Disease.
"Compared to what we expected based on a prior ...
In recent years, developers have been investigating light-harvesting thin film solar panels made from nanotechnology –– and promoting efficiency metrics to make the technology marketable. Now a Tel Aviv University researcher is providing new evidence to challenge recent "charge" measurements for increasing solar panel efficiency.
Offering a less expensive, smaller solution than traditional panels, Prof. Eran Rabani of Tel Aviv University's School of Chemistry at the Raymond and Beverly Sackler Faculty of Exact Sciences puts a lid on some current hype that promises to ...
A new study conducted by Josh LaBaer's research team in the Biodesign Institute at Arizona State University has pinpointed more than 30 breast cancer gene targets ---including several novel genes---that are involved in drug resistance to a leading chemotherapy treatment.
The results of the study may one day aid in the treatment of the one in ten U.S. women who will develop breast cancer, by empowering physicians with a more personalized approach to therapy as well as a new tool for the early screening of those that may ultimately become resistant to chemotherapy.
Drugs ...
